NACDS to Congress: Don't mandate track and trace
In testimony before Congress, an NACDS executive argues that track and trace should not be required.
Rather than require a track and trace system to be implemented to ensure product integrity, a program should be set up by the Food & Drug administration to certify that manufacturers, wholesalers, and pharmacies have complied with secure supply chain practices. That was one of the recommendations Kevin Nicholson, R.Ph., J.D., VP of pharmacy regulatory affairs at the National Association of Chain Drug Stores, made in testimony at a House Energy & Commerce Subcommittee on Health hearing last week. Nicholson explained that a track and trace system is expensive and fraught with technical difficulties. He suggested, instead, that a pedigree be required of noncertified supply chain entitites and other measures.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025
March 31st 2025Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.
